End-to-end evidence generation for better type 2 diabetes studies
Diabetes is one of the fastest growing health challenges of the 21st century. Type 2 diabetes is most common, and cases are on the rise globally. Signant SmartSignals evidence generation solutions support type 2 diabetes studies with a range of digital tools designed to increase efficiencies and reduce common burdens. We support these solutions with a dedicated team of clinical science and global clinical operations experts to ensure your study results in accurate, verifiable, and regulatory-compliant data.
We Have Solutions to Help Your Study Succeed
Paper diaries and other PRO reporting tools are not only outmoded, but they do not produce the accurate, legible, or contemporaneous entries your clinical study requires. Our eCOA solution provides a simple eDiary, customizable to accommodate quality-of-life challenges for people with type 2 diabetes including brighter screens, and larger buttons and fonts. Notifications and prompts to ensure timely and reliable data.
Participant-Centric eCOA
Accurate Blood Glucose Measurement Data, Less Effort
Blood glucose meters play an important role in type 2 diabetes studies – that’s why we chose a research-grade blood glucose meter with proven accuracy, excellent reliability, and accessibility characteristics to integrate with our eDiary. Measurement data is automatically uploaded to the eDiary, providing a better experience for study participants and near to real-time data access for the research team.
Improved Study Participant Retention
Keeping study participants compliant with PRO requirements and committed to your type 2 diabetes research study is the goal of our Patient Concierge solution, which provides helpful training, reminders, and video-based telehealth consultations so participants are more likely to meet requirements and complete the study.
Accommodations for All Ages and Abilities
Signant Health’s solutions are designed around participant experience, reflecting our own research and practice working with different populations including older participants in type 2 diabetes studies. Adaptable technology, tailored training and documentation, and built-in reminders support participants, their caregivers, or those with quality-of-life challenges.
Minimized Burdens for Participants, Sites, & Study Teams
Our eCOA, eConsent, Patient Concierge, and RTSM solutions are designed to address complexities in type 2 diabetes research by reducing typical burdens for sponsors, sites, and participants. Each is supported by a dedicated project team consisting of therapeutic area and global operations experts.
COUNTRIES
41
36,000
PATIENTS
4,300+
SITES
STUDIES
36
II - IV
PHASES
Our Type 2 Diabetes
Experience by the Numbers
Type 2 Diabetes
Solutions
Type 2 Diabetes Trial Solution Resources
Signant's Subject Matter Experts
Comprehensive Type 2 Diabetes Trial Solutions
Enhance Your Type 2 Diabetes Clinical Trials with Signant
PATIENT CONCIERGE
RTSM
eCOA
eCONSENT
LEARN MORE 🠖LEARN MORE 🠖LEARN MORE 🠖LEARN MORE 🠖
